Illumina | ILMN - Cost Of Sales


Illumina reported $400M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Bio Techne USD 104.6M 6.16M Dec/2025
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
Boston Scientific USD 1.83B 8M Mar/2026
Bruker USD 528M 46.9M Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 518M 55M Dec/2025
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Illumina USD 400M 49M Dec/2025
Intuitive Surgical USD 940.3M 21.6M Mar/2026
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Quidel USD 448.8M 1.21B Dec/2025
Repligen USD 94.08M 5.79M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Standard Biotools USD 12.41M 2.34M Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Waters USD 374.94M 47.13M Dec/2025